• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Venture

Spex Capital launches EUR 100m early-stage healthtech fund

  • Rachel Lewis
  • 27 February 2023
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Emerging manager Spex Capital has launched a EUR 100m global health tech fund in a bid to take advantage of softened valuations, founder Claudio Dт€™Angelo told Unquote.

Spex Venture HealthTech Fund, which was incorporated in Luxembourg in January, has so far received letters of intent from LPs worth around EUR 30m-40m that it hopes will soon be signed with new allocations becoming available, he said.

The Article 9 fund could raise up to EUR 150m, he added, as it hopes to gain some traction among other LPs in the next three months.

Once the capital has been committed, the UK-based firm will hold a rolling close to start deployment with 6-7 companies already identified as plausible targets from its first investment call, D'Angelo said.

The GP is launching the fund at a time when many LPs are preferring to allocate to established managers amid a capital crunch caused by the denominator effect.

"It is a very difficult time but we are seeing renewed interest now," D'Angelo said. "We want to launch now because all of the tech valuations tanked in 2022 and we can invest at softer valuations in survivalist companies that will probably have a good runway."

However, Spex has already completed six investments outside of the fund structure, including teledermatology provider Skin Analytics and digital-first health check-up company Live Smart. 

While Spex is for now focused on launching the health tech fund, it also has its sights set on further impact verticals, including food tech and climate tech. Spex Venture HealthTech Fund has been set up as a feeder vehicle into a wider investment impact fund to help attract wider LPs with an impact mandate.

The GP is also collaborating with a rating agency to develop a methodology for measuring impact that it hopes will become a benchmark across private assets.

Credit Suisse is the administrator and Deloitte the auditor of the 10-year closed fund.

To bolster the team, it has also hired Brent Stackhouse from Mount Sinai Ventures, to bring in experience of investing in the US and help portfolio companies expand overseas. 

Investments
The fund will look to invest in early-stage to Series A healthtech companies, with a focus on Europe. For early stage, it will look for an enterprise value (EV) of around EUR 5m-8m, deploying tickets of EUR 0.5m-2m, and Series A will look at EVs of EUR 20m-50m, with tickets up to EUR 5m.

It can invest similar size tickets into Series B companies where it has already invested but will not actively seek late-stage opportunities.

It is agnostic across health tech but sees mental health, chronic disease and femtech as particularly interesting subsectors.

Spex expects to make around 50 investments over the next four years, with around 70% of its investments based in the UK and Europe despite it being a global fund.

To help inform its investments, Spex has partnered with NHS accelerator DigitalHealth.London and life sciences hub MedCity, both based in the UK.

"Together with them we launched investment calls and within 6-8 weeks we attracted over 100 companies. This was done through a survey platform adapted for investments that can really help us separate the winners from the losers," D'Angelo said.

The GP has also already signed a partnership with a foodtech community that can help validate investments in that sector, once it launches future vehicles.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Venture
  • UK / Ireland
  • Healthcare
  • GPs
  • healthcare
  • impact investing
  • Exclusive

More on Venture

Redalpine expands leadership team amid CHF 1bn-plus fundraise
Redalpine expands leadership team amid CHF 1bn-plus fundraise

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • Venture
  • 31 August 2023
VC Profile: RTP Global gears up to deploy largest fund to date, remains bullish on breakout opportunities
VC Profile: RTP Global gears up to deploy largest fund to date, remains bullish on breakout opportunities

Partner Gareth Jefferies discusses early-stage deployment plans and advantages of supporting startups throughout their lifecycle

  • Venture
  • 14 August 2023
Medicxi raises USD 400m to invest in single-focus life sciences companies
Medicxi raises USD 400m to invest in single-focus life sciences companies

GP's fourth fund will deploy USD 10m-USD 20m tickets in narrow indications of unmet need; backed by pharma

  • Venture
  • 27 July 2023
Women in PE: Earth Capital's Bezuidenhoudt and Hockley on 2024 fund launch progress and co-investment pipeline
Women in PE: Earth Capital's Bezuidenhoudt and Hockley on 2024 fund launch progress and co-investment pipeline

UK-based impact investorт€™s female leaders discuss deployment plans and the advantages of its syndicate co-investment strategy

  • Venture
  • 21 July 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013